AlphaOS

Coverage building

SCNI has basic price and filing data (40% intelligence coverage), but earnings analysis, financial metrics, and proprietary signals are still building. Explore a peer with deeper coverage below.

Deeper coverage nearby

Intelligence coverage: 40%

Basic profile, financials, and market data are shown below. Deep research is building in the background.

SCNI

Scinai Immunotherapeutics Ltd.

Healthcare · Biological Products, (No Diagnostic Substances)

$1.41Sep 29, 2026

AI confidence 50% · prior close shown (market closed)

Investment Snapshot

Limited proprietary earnings coverage for SCNI yet — signals will sharpen as filings and earnings are ingested.

Pipeline evidence · 79d ago

SCNI's AlphaOS Signals

Upgrade to Pro for validated historical pattern analysis on SCNI.

Create free account

Free accounts see more of this; Premium sees all of it.

Latest Intelligence

Updated

What happened recently for Scinai Immunotherapeutics Ltd. (SCNI) — events, not interpretation.

Event
Last session September 29, 2026 at $1.41.
Source
Market data

Research & analysis only — not investment advice.

Building company intelligence…

Scinai Immunotherapeutics Ltd. (SCNI)

Healthcare · Biological Products, (No Diagnostic Substances)

Investment Snapshot above is the primary AlphaOS analysis for Scinai Immunotherapeutics Ltd. — structured signals and evidence from proprietary pipelines, not an encyclopedia overview.

Key facts

Sector:
Healthcare
Industry:
Biological Products, (No Diagnostic Substances)
Market cap:
$19.56B
Revenue:
$1.31M

SCNI earnings analysis

Research & analysis only — not investment advice. Price, charts, and filings are above.

Connected intelligence

Follow Scinai Immunotherapeutics Ltd. through AlphaOS's knowledge graph — themes, peers, beneficiaries, earnings, and research answers.

Related stock research

Connected companies and research pages from the AlphaOS knowledge graph.